Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The phase 3 TRIUMPH-4 data showed these rates at 9 mg and 12 mg doses respectively: Nausea: 38.1% and 43.2% (vs 10.7% placebo) Diarrhea: 34.7% and 33.1% (vs 13.4% placebo) Constipation: 21.8% and 25.0% (vs 8.7% placebo) Vomiting: 20.4% and 20.9% (vs placebo) These numbers are higher than cagrilintide monotherapy across the board
Broader peptide therapy or hormone optimization planning
Life Extension - Why We Do It
What does PDRN do for skin
Pricing depends on the formulation and whether you choose a single session or a series, and it is confirmed at your consultation rather than quoted as a fixed number online
One treatment round of 10 IVs can lighten your skin to 1 to 3 shades
